Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEB071 versus tacrolimus in de novo adult renal transplant recipients
2006-004128-35Phase 2Terminated
- Sponsor
- Novartis
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sotrastaurin in kidney allograft rejection (2 arms), sponsored by Novartis. Primary endpoint: Composite efficacy failure at 3 months. Started Oct 2006; status: terminated.
02
Drugs
sotrastaurin
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2006-004128-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004128-35.